StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
EBSEmergent BioSolutions Inc.
stockpulse.co.kr
NYSE
$6.27▲ 0.72%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $323.5MShares out 51.6M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

11
  • 10.16Pre-market26.10.16 20:48
    8-KKey event#●●●

    Emergent BioSolutions Inc.

    Emergent BioSolutions announced that CFO Richard Lindahl will retire effective December 31, 2026. Frank Vargo, Vice President and Treasurer, will assume the role of interim CFO starting January 1, 2027, with Lindahl serving as a senior executive advisor through March 31, 2027, to ensure a smooth transition.…more

    $6.27+0.72%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 10.7After-hours26.10.08 05:03
    144Ownership

    Emergent BioSolutions Inc.

    Donald W. DeGolyer, an insider at Emergent BioSolutions Inc., has filed an SEC Form 144 to report a proposed sale of company shares. This is a standard filing disclosing the insider's plan to dispose of their holdings.…more

    $6.27+0.72%vs prev close
    View filingShare
  • 10.7Regular26.10.08 04:45
    4Ownership

    Emergent BioSolutions Inc.

    Insider Donald W. DeGolyer of Emergent BioSolutions Inc. filed a Form 4 statement regarding changes in beneficial ownership of securities on October 7, 2026. This filing discloses the insider's transaction activity, providing transparency into the company's governance and insider holdings.…more

    $6.27+0.72%vs prev close
    View filingShare

10 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 10.16Pre-market26.10.16 20:50
    #●●●

    Emergent Biosolutions Appoints Frank Vargo as Interim CFO

    Emergent Biosolutions has appointed Treasurer Frank Vargo as the interim CFO, succeeding Richard Lindahl. The appointment is set to take effect on January 1, 2027.…more

    $6.27+0.72%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga
  • 10.8Pre-market26.10.08 18:59

    ●●●●●●●● ●●●●● ●●●●●●

    Russian authorities have officially denied media reports regarding a second case of illness in the Siberia region. This development does not contain specific economic data or corporate information that would impact the markets.…more

    $6.27+0.72%vs prev close
    ShareBenzinga
  • 9.15Pre-market26.09.15 20:45

    ●●●●●●●● ●●●●● ●●●●●●

    Emergent BioSolutions will hold a ribbon-cutting ceremony to mark the restart and expansion of its manufacturing facility in Canton, Massachusetts. The company plans to create approximately 50 new jobs as part of its investment in advanced biopharmaceutical manufacturing.…more

    $6.27+0.72%vs prev close
    Read sourceShareGlobeNewswire

2 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →